• All Share : 52511.86
    UP 1.20%
    Top40 - (Tradeable) : 46258.26
    UP 1.15%
    Financial 15 : 14759.03
    UP 1.56%
    Industrial 25 : 71376.3
    UP 0.97%
    Resource 10 : 30586.28
    UP 1.35%

  • ZAR/USD : 14.7003
    DOWN -0.60%
    ZAR/GBP : 19.7133
    DOWN -0.58%
    ZAR/EUR : 16.3628
    DOWN -0.44%
    ZAR/JPY : 0.143
    DOWN -0.14%
    ZAR/AUD : 10.9409
    DOWN -0.55%

  • Gold US$/oz : 1317.9
    DOWN -0.03%
    Platinum US$/oz : 1003
    DOWN -0.50%
    Silver US$/oz : 18.41
    UP 0.77%
    Palladium US$/oz : 590
    UP 0.34%
    Brent Crude : 49.64
    DOWN -1.14%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Thu Jun 30 15:58:36 CAT 2016

Samsung Galaxy S III sales top 30 million

Sapa-AFP | 04 November, 2012 11:28
A woman holds her new Samsung Galaxy S III. File photo.
Image by: OLIVIA HARRIS / Reuters

Samsung Electronics said Sunday that global sales of its flagship Galaxy S III smartphone had topped 30 million since its debut in May.

"The Galaxy S III continues to be a runaway favourite with customers around the world," JK Shin, head of Samsung's IT and mobile communications division, said in a statement.

The third version of the Galaxy S series offers a more powerful processor that lets users watch video and write emails simultaneously as well as a large 4.8-inch screen.

The company sold 56.3 million smartphones, including its flagship S III, in July-September, representing 31.3% of the global market, more than twice as much as bitter rival Apple's share, research firm IDC said last month.

Samsung and US rival Apple have been embroiled in a long-running patent battle in 10 countries, including the United States and Germany, with the pair accusing each other of stealing designs and technology.

In August Samsung was ordered to pay Apple $1.05 billion in damages for illegally copying iPhone and iPad features for its Galaxy S smartphones, but a Japanese court later rejected Apple's claim that Samsung stole its technology.


If you have an opinion you would like to share on this article, please send us an e-mail to the Times LIVE iLIVE team. In the mean time, click here to view the Times LIVE iLIVE section.